Filing Flows › ASP Isotopes (ASPI) › R&D spending
ASP Isotopes (ASPI) R&D spending by quarter
ASP Isotopes' R&D spending was $6.8M in Q2 2026 (second quarter 2026), +30% from Q1 2026. Over the last 7 quarters it ranged from $880K (Q2 2025) to $6.8M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $6.8M | +30% | +675% |
| Q1 2026 | $5.3M | -23% | +244% |
| Q4 2025 | $6.8M | +121% | +384% |
| Q3 2025 | $3.1M | +252% | — |
| Q2 2025 | $880K | -42% | — |
| Q1 2025 | $1.5M | +8% | — |
| Q4 2024 | $1.4M | — | — |
Q2 2026 at a glance
ASP Isotopes, Q2 2026: revenue $5.1M (+328% year over year), operating margin -667.5%, net loss $34.0M, operating cash flow −$23.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is ASP Isotopes' R&D spending?
ASP Isotopes' R&D spending was $6.8M in Q2 2026 (second quarter 2026), +30% from Q1 2026.
How has ASP Isotopes' R&D spending changed?
Over the last 7 quarters it ranged from $880K (Q2 2025) to $6.8M (Q4 2025).